(Q38714524)

5 September 2017

title

Geniposide protects pancreatic β cells from high glucose-mediated injury by activation of AMP-activated protein kinase (English)

1 reference

5 September 2017

Chunyan Liu

1 reference

5 September 2017

Yanan Hao

1 reference

5 September 2017

Fei Yin

1 reference

5 September 2017

Yonglan Zhang

1 reference

5 September 2017

Jianhui Liu

1 reference

5 September 2017

publication date

28 February 2017

1 reference

Cell Biology International

5 September 2017

published in

1 reference

5 September 2017

1 reference

5 September 2017

1 reference

5 September 2017

page(s)

544-554

1 reference

Diabetes complications in childhood and adolescent onset type 2 diabetes-a review

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

AMPK: a cellular energy sensor primarily regulated by AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

The changing face of diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Geniposide Suppresses Hepatic Glucose Production via AMPK in HepG2 Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

AMPK--sensing energy while talking to other signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

AMPK: positive and negative regulation, and its role in whole-body energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Glucotoxicity and beta-cell failure in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Protective Effect of Heme Oxygenase-1 on High Glucose-Induced Pancreatic β-Cell Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced β-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

AMP-activated protein kinase and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Type 2 diabetes-a matter of beta-cell life and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

β-aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Diabetes. Paradoxical effects of tightly controlled blood sugar

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Geniposide protects against acute alcohol-induced liver injury in mice via up-regulating the expression of the main antioxidant enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Melatonin is involved in the apoptosis and necrosis of pancreatic cancer cell line SW-1990 via modulating of Bcl-2/Bax balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

GLP-1 receptor plays a critical role in geniposide-induced expression of heme oxygenase-1 in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

AMPK activators as novel therapeutics for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Identification of a new anti-LPS agent, geniposide, from Gardenia jasminoides Ellis, and its ability of direct binding and neutralization of lipopolysaccharide in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10758

21 January 2018

Identifiers

DOI

10.1002/CBIN.10758

1 reference

5 September 2017

1 reference